Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Multiple Myeloma × Methotrexate × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 21 Burkitt Lymphoma 15 Leukemia, Biphenotypic, Acute 9 Leukemia, Myeloid, Acute 8 Myelodysplastic Syndromes 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Medulloblastoma 4 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3 Osteosarcoma 3 Neoplasm Metastasis 3 Lymphoma 3 Leukemia 3 Urinary Bladder Neoplasms 2 Recurrence 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Leukemia, Myelomonocytic, Juvenile 2 Leukemia, Myeloid, Accelerated Phase 2 Graft vs Host Disease 2 Blast Crisis 2 Squamous Cell Carcinoma of Head and Neck 1 Shwachman-Diamond Syndrome 1 Sarcoma, Ewing 1 Rhabdoid Tumor 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Primary Myelofibrosis 1 Philadelphia Chromosome 1 Neoplasm, Residual 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1

Interventions

Dexamethasone 108 Lenalidomide 73 daratumumab 59 Bortezomib 49 pomalidomide 40 carfilzomib 39 Calcium Dobesilate 38 Cyclophosphamide 27 Specimen Handling 25 Biopsy 23 talquetamab 19 isatuximab 19 Magnetic Resonance Spectroscopy 19 fludarabine 17 iberdomide 15 dexamethasone acetate 14 dexamethasone 21-phosphate 14 belantamab mafodotin 14 auricularum 14 selinexor 13 elotuzumab 10 tocilizumab 9 fludarabine phosphate 8 trametinib 6 ixazomib 6 X-Rays 6 Melphalan 6 venetoclax 5 Whole-Body Irradiation 5 nirogacestat 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04960579 2026-03-13

MM

Poseida Therapeutics, Inc.

Phase 1 Recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡